Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)

Well-differentiated grade 3 neuroendocrine tumors (NET G3) have been distinguished from poorly differentiated neuroendocrine carcinomas (NEC) in the most current WHO classifications. Commonly applied first-line chemotherapy protocols with cisplatin or carboplatin in combination with etoposide (PE) a...

Full description

Bibliographic Details
Main Authors: Leonidas Apostolidis, Arianna Dal Dal Buono, Elettra Merola, Henning Jann, Dirk Jäger, Bertram Wiedenmann, Eva Caroline Winkler, Marianne Pavel
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
NET G3
neuroendocrine tumor
neuroendocrine carcinoma
systemic therapy
chemotherapy
peptide receptor radionuclide therapy
Online Access:https://www.mdpi.com/2072-6694/13/8/1936

Internet

https://www.mdpi.com/2072-6694/13/8/1936

Similar Items